Skip to main content
Log in
Menu
Find a journal
Publish with us
Track your research
Search
Cart
Home
Inpharma Weekly
Volumes and issues
Volume 1633, Issue 1
Inpharma Weekly
Publishing model
:
Subscription
Inpharma Weekly
is now archived and no longer receiving submissions with this publisher. All articles published in the journal during its time with Springer will remain fully searchable through our websites.
Search all Inpharma Weekly articles
Volume 1633, Issue 1
April 2008
64 articles in this issue
Celecoxib CV risk increased at higher dosages
News item
02 February 2013
Pages: 21 - 21
Lumiracoxib withdrawn in Australia
News item
02 February 2013
Pages: 21 - 21
US FDA black box warning for UCAs may be harmful
Clinical study
02 February 2013
Pages: 21 - 21
Biolimus A9-eluting stent launched across Europe
Media release
02 February 2013
Pages: 22 - 22
Deferiprone okayed for iron overload in Australia.
Media release
02 February 2013
Pages: 22 - 22
First peripheral drug-eluting stent launched in NZ.
Media release
02 February 2013
Pages: 22 - 22
Galsulfase approved in Japan.
Media release
02 February 2013
Pages: 22 - 22
Prempro affects breast cancer detection
Clinical study
02 February 2013
Pages: 22 - 22
Rotavirus vaccine gets the go ahead in the US
Media release
02 February 2013
Pages: 22 - 22
US FDA approves ANDA for fosphenytoin.
Media release
02 February 2013
Pages: 22 - 22
Bird flu vax approved in China.
Media release
02 February 2013
Pages: 23 - 23
Methylnaltrexone approved for OIC in Canada.
Media release
02 February 2013
Pages: 23 - 23
Rilonacept launched in the US for CAPS.
Media release
02 February 2013
Pages: 23 - 23
Zotarolimus-eluting stent approved for CAD in Canada.
Media release
02 February 2013
Pages: 23 - 23
Previous
page
1
2
Search
Search by keyword or author
Search
Navigation
Find a journal
Publish with us
Track your research